People are buying healthier snacks and household food bills are dropping as GLP-1 weight-loss drugs alter eating habits.

Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

Experts warn federal spending cuts will make the country sicker and poorer as healthcare costs rise without new treatments.

Global Partners LP (NYSE:GLP) reported a revenue of $4.19 billion in Q4 of 2024, missing estimates by $1.62 billion. EPS was ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

After making waves globally and helping people lose weight—not counting the side effects—the wonder-drug Ozempic is now in ...

“Coverage of GLP-1s is not necessarily in-your-face obvious. It leads to the conversation of whether we want to pursue weight loss through drug products or something like a wellness program.

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities ...